pirinixic acid has been researched along with Cancer of Kidney in 2 studies
pirinixic acid: structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, R | 3 |
| Zhao, J | 3 |
| Jin, J | 3 |
| Tian, Y | 3 |
| Lan, L | 3 |
| Wang, X | 3 |
| Zhu, L | 3 |
| Wang, J | 3 |
| Cunningham, ML | 1 |
| Elwell, MR | 1 |
| Matthews, HB | 1 |
2 other studies available for pirinixic acid and Cancer of Kidney
| Article | Year |
|---|---|
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
Relationship of carcinogenicity and cellular proliferation induced by mutagenic noncarcinogens vs carcinogens. III. Organophosphate pesticides vs tris(2,3-dibromopropyl)phosphate.
Topics: Animals; Cell Division; DNA Damage; Insecticides; Kidney; Kidney Neoplasms; Liver; Liver Neoplasms; | 1994 |